IHUB...Vascepa /Argentina COVID19 Trial + AMRN Response to a Shareholder Query re. Patent Protectio | AMRN Message Board Posts

Amarin Corporation plc

  AMRN website

  •  Registered Members of Investor Village:
    Please make sure you are signed in to your Investor Village account to enjoy the full benefits of our service and avoid the MediaPass paywall. If the MediaPass offer page is blocking you, click the light blue "No thanks, take me back" link on the middle right side of the form to get to our home page where you can sign in by entering your Investor Village User Name and Password. 

     MediaPass subscribers: Please make sure you are logged in to your MediaPass subscription to bypass the paywall. You can do this by clicking the light blue "Already have a MediaPass account? Login here" link on the middle left side of the subscription offer form and then entering the email address and password you used when you first signed up with MediaPass.  

    For assistance call 888-222-7309 or email admin@investorvillage.com

AMRN   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  7331 of 7355  at  6/26/2020 2:26:14 PM  by

ex_hacker202


 In response to msg 7328 by  Q77
view thread

Re: IHUB...Vascepa /Argentina COVID19 Trial + AMRN Response to a Shareholder Query re. Patent Protection Comment

  Results aren't expected for about a year IIRC. No idea whether they'll release any informal interim results like MRNA did for a few patients in their P1 CV-19 vaccine trial - they raised $1.4B in a secondary after leaking those results but the full data set still hasn't been released, although it's the NIAID's data, not MRNA's - the NIAID also has a few patents for part of that vaccine, MRNA doesn't own it outright.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 118
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
7332 Re: IHUB...Vascepa /Argentina COVID19 Trial + AMRN Response to a Shareholder Query re. Patent Protection Comment Q77 1 6/26/2020 2:55:11 PM






About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...